AIDX· Health Care› Medical Devices

20/20 Biolabs, Inc.

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. More about the company

$0.25

-7.22% today

$3.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is AIDX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2026-02-19 → 2026-10-22

S? 35w

2026-02-192026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 35w current

Total tracked: 35 weeks across 1 stage run.

AIDX among Medical Devices140th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…140	AIDX20/20 Biolabs, Inc.	—	—	−41.7%

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 35

1w13w26w

Week 35, mature

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

1.30x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-41.7%

-48.8%

-84.5%

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S—

Wk 35 · Vol 1.30x

2026-10-21S—

Wk 34 · Vol 0.19x

2026-10-20S—

Wk 34 · Vol 1.55x

2026-10-19S—

Wk 34 · Vol 4.40x

2026-10-16S—

Wk 34 · Vol 2.14x

2026-10-15S—

Wk 34 · Vol 3.27x

2026-10-14S—

Wk 33 · Vol 3.27x

2026-10-13S—

Wk 33 · Vol 0.99x

2026-10-12S—

Wk 33 · Vol 2.25x

2026-10-09S—

Wk 33 · Vol 0.79x

2026-10-08S—

Wk 33 · Vol 2.34x

2026-10-07S—

Wk 32 · Vol 0.95x

Moving averages & range

50 DMA

$0.46

200 DMA

—

52W High

—

52W Low

—

5D Low

$0.25

Resistance levels (recent highs)

20d High

$0.44

60d High

$0.63

120d High

$1.52

250d High

—

Next resistance

+75.5%

to 20d High

ROE

-331.2%

Profit margin -285.0%

Dividend Yield

0.00%

P/B 1.9

20/20 Biolabs: quick answers

Which sector and industry is 20/20 Biolabs in?

20/20 Biolabs is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.